PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy

INTRODUCTION: Xerostomia is a well-known complication after iodine-131 ((131)I) therapy for thyroid carcinoma. It is currently insufficiently understood how the dose and biodistribution of (131)I relates to salivary gland toxicity, and whether this is consistent for all salivary glands within a sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Vineet, Vogel, Wouter V., Valk, Gerlof D., de Boer, Jan P., Lam, Marnix G. E. H., de Keizer, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493237/
https://www.ncbi.nlm.nih.gov/pubmed/32619138
http://dx.doi.org/10.1177/1536012120934992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493237/
https://www.ncbi.nlm.nih.gov/pubmed/32619138
http://dx.doi.org/10.1177/1536012120934992

Ejemplares similares